The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.

PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.

Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.

Schreiner MediPharm, a global provider of functional label solutions for the healthcare industry, has introduced the Smart ...

OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...

Great Point Partners (GPP), a private investment firm focused on the health care industry, has acquired a majority stake in ...

Simtra BioPharma Solutions, a CDMO specializing in sterile injectables, has formed a five-year strategic alliance with the ...

Sanyou Biopharmaceuticals, a Shanghai-based biopharmaceutical company specializing in biologics R&D, signed a strategic ...

The collaboration will create a path from concept to preclinical development of complex diseases in the Biopharmaceutical ...

This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

Rod Ketner on Serán BioScience’s science-first culture and what biotechs should look for in a CDMO.

Glycovax has refined its production to meet regulatory requirements and will market the protein through its subsidiary Espoir ...